Advertisements



INmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder Update

LA JOLLA, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), an immunology company developing treatments that harness the patien.....»»

Category: earningsSource: benzingaNov 8th, 2019

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2019 Financial Results

Strengthened management team with the appointment of Nicole Rusaw as Chief Financial Officer Cash and cash equivalents of CAD$20.3 million as of July .....»»

Category: earningsSource: benzingaOct 2nd, 2019

Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH, OTCQX:EMHTF) reported fin.....»»

Category: earningsSource: benzingaMay 14th, 2020

francesca"s® Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Update on COVID-19 Pandemic Response

Fourth quarter net sales were flat at $119.0 million and comparable sales increased 1% Fourth quarter GAAP loss per share was $3.97 Fourth quarter adjusted loss per share was $0.31 (see No.....»»

Category: earningsSource: benzingaMay 1st, 2020

Vibe Reports Financial Results for Fourth Quarter and Year Ended December 31, 2019 and Provides Operational Update

SACRAMENTO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Vibe Bioscience Ltd. (CSE:VIBE)(OTC:VBSCF)  (the "Company" or "Vibe"), a vertically integrated cannabis r.....»»

Category: earningsSource: benzingaApr 30th, 2020

BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update

- FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust Clinical Measure to Evaluate Superiority in CIN - - Initiated NDA Rolling Submission for Plinabulin for CIN in China in Q1 2020 - - On Track.....»»

Category: earningsSource: benzingaApr 30th, 2020

Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.....»»

Category: earningsSource: benzingaApr 16th, 2020

Bellerophon Provides Clinical Program Update and Reports Fourth Quarter and Full-Year 2019 Financial Results

WARREN, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH), a clinical-stage biotherapeutics company focused on developing treatme.....»»

Category: earningsSource: benzingaApr 6th, 2020

RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused o.....»»

Category: earningsSource: benzingaMar 30th, 2020

LXRandCo Reports Financial Results for the Fourth Quarter 2019 and the Full Year 2019, and Provides Update on the Possible Impact of Coronavirus (COVID-19) on its Operations

MONTREAL, March 26, 2020 /CNW/ - LXRandCo, Inc. ("LXRandCo" or the "Company") (TSX:LXR, LXR.WT)), a North American omni-channel .....»»

Category: earningsSource: benzingaMar 26th, 2020

ONCOCYTE PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

ONCOCYTE PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS.....»»

Category: earningsSource: benzingaMar 25th, 2020

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update

U.S. Food.....»»

Category: earningsSource: benzingaMar 24th, 2020

IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using .....»»

Category: earningsSource: benzingaMar 24th, 2020

Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update

LEXINGTON, Mass., March 19, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focus.....»»

Category: earningsSource: benzingaMar 19th, 2020

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update.....»»

Category: earningsSource: benzingaMar 19th, 2020

Catalyst Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update

-Firdapse® Q4 Net Revenues of $30 Million, FY 19 Net Revenues of $102 Mil.....»»

Category: earningsSource: benzingaMar 16th, 2020

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.....»»

Category: earningsSource: benzingaMar 16th, 2020

Allena Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Provides Business Update

-- Streamlined URIROX-2 Design Potentially Reduces Target Length and Cost of Trial -- -- Regulatory Engagement on Regi.....»»

Category: earningsSource: benzingaMar 16th, 2020

Aerpio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Aerpio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaMar 16th, 2020

Intec Pharma Reports Fourth Quarter and Year End 2019 Financial Results and Corporate Update

JERUSALEM, March 13, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Com.....»»

Category: earningsSource: benzingaMar 13th, 2020

Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

PALO ALTO, Calif., March 13, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial resul.....»»

Category: earningsSource: benzingaMar 13th, 2020